Published on 11 Jun 2022 on Simply Wall St. via Yahoo Finance
Further weakness as Sorrento Therapeutics (NASDAQ:SRNE) drops 12% this week, taking one-year losses...
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shareholders should be happy to see the share price up 22% in the last month. But that doesn't change the fact that the returns over the last year have been stomach churning. Indeed, the share price is down a whopping 83% in the last year. So the rise may not be much consolation. Only time will tell if the company can sustain the turnaround. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.
Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.
View our latest analysis for Sorrento Therapeutics